ATOS: Atossa Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 169.16
Enterprise Value ($M) 81.28
Book Value ($M) 91.02
Book Value / Share 0.73
Price / Book 1.86
NCAV ($M) 86.98
NCAV / Share 0.69
Price / NCAV 1.94

Profitability (mra)
Return on Invested Capital (ROIC) -0.38
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 17.33
Current Ratio 17.61

Balance Sheet (mrq) ($M)
Current Assets 92.22
Assets 96.25
Liabilities 5.24
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -31.38
Net Income -34.44
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -20.94
Cash from Investing -0.01
Cash from Financing -1.48

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-19 207,535 1,086,259 19.11
2024-04-18 216,433 2,324,428 9.31
2024-04-17 485,631 4,115,472 11.80
2024-04-16 353,639 1,719,050 20.57
2024-04-15 321,185 1,606,370 19.99

(click for more detail)

Similar Companies
ASNS – Actelis Networks, Inc. ASRT – Assertio Holdings, Inc.
ATNF – 180 Life Sciences Corp. ATXI – Avenue Therapeutics, Inc.
AVTX – Avalo Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io


Finpedia: Atossa Genetics